osteoporosis Flashcards
pharmacological tx for osteoporosis
bisphosphonate
denosumab
raloxifene
teriparatide
hormone replacement therapy
Essential factors for bone densit
Vit D
Ca
Sex hormone
PTH hormone
Bone homeostasis
Body parts which are more susceptible to fracture
wrist
Hip
Lower back
Bisphophonate (oral) has to be used for how long
5 yrs
Bisphosphonate MOA
inhibit the activity of osteoclast
should bisphosphonate be taken w food ? Y/N
N—poor absorptio
should ca2+ supplement be taken w bisphosphonate Y/N
N—inhibit the absorption of bisphosphonate
denosumab MOA
inhibit RANKL —-inhibit the activsation of osteoclast
there is no need to correct vit D deficiency before starting the denosumab Y/N
N (denosumab wll cause hypocalcaemia
raloxifene MOA
estrogen agonist in bone
raloxifene is more appropriate for preventing spinal fracture Y/N
Y
teriparatide MOA
promote the bone formation
only specialist can initiate the teriparatide tx Y/N
Y
HRT is not recommended for patient age > 60 Y/N
Y
HRT is not recommended for the solely purpose of preventing osteoporosis Y/N
Y